5 Top Stock Gainers for Tuesday: ImmunoGen, Immunity Bio, Navigator

Stocks slumped on Tuesday, as Treasury bond yields and oil prices fell, amid concerns over the new omicron Covid variant.

Here are some of the top winners on Tuesday:

1. ImmunoGen | 23% increase

ImmunoGen (IMGN) – Get the report from ImmunoGen, Inc. Shares soared after cancer drug specialists said her treatment for ovarian cancer met primary goals in an advanced-stage study. ImmunoGen said that mirvetuximab, its treatment for patients with platinum-resistant ovarian cancer, performed well in a pivotal SORAYA trial.

2. BioImmunity | 15% increase

ImmunityBio actions (IBRX) climbed after EnGeneIC, an Australian biotech, granted the company an exclusive global development license through the commercialization of its EnGeneIC Dream Vector in combination with its cancer drugs and the Covid-19 vaccine.

3. Browser backgrounds | 11% increase

Browser backgrounds (NVGS) – Get the report from Navigator Holdings Ltd. rose after the liquefied petroleum gas carrier beat Wall Street’s third-quarter revenue and revenue estimates. The company reported earnings of 10 cents per share, beating Zacks’ consensus estimate of 6 cents per share, and before the previous year, the figure of 3 cents per share.

4. Identity | 5.4% increase

Identiv actions (INVE) – Get the report from Identiv, Inc. advanced after CVS (CVS) – Get the CVS Health Corporation report said the security technology company will power the pharmacy operator’s proprietary Spoken Rx audio prescription label solution, which was developed in conjunction with the American Council of the Blind.

Citi Trends (CTRN) – Get the Citi Trends, Inc. shares rose after the fashion clothing retailer beat Wall Street earnings expectations in the third quarter. The company reported quarterly profit of $ 1.03 per share, down from 67 cents a year ago and beating Zacks’ consensus estimate of 48 cents per share.

Comments are closed.